Fig. 3From: No preclinical rationale for IGF1R directed therapy in chondrosarcoma of boneOSI-906 does not inhibit migration of four chondrosarcoma cell lines. 72H OSI 1Â ÎĽM: cells were treated for 72Â hours with OSI-906 before experimental onsetBack to article page